Small pharma companies tend to have one product or technology that could make them a highly successful investment. In some cases, there is a well advanced second treatment using different life sciences technology.
This pharma company has a treatment to prevent serious infections that has already had highly positive phase 2b clinical study results. The next step will be the design of a phase 3 clinical study.
There is also a second, acquired technology that could move to a phase 3 clinical study next year. This is another antimicrobial drug to prevent serious infections.
The share pri...
